Descriptor English: | Mitoxantrone | ||||||
Descriptor Spanish: |
Mitoxantrona
| ||||||
Descriptor Portuguese: | Mitoxantrona | ||||||
Descriptor French: | Mitoxantrone | ||||||
Entry term(s): |
Acetate, Mitoxantrone CL 232325 CL-232325 CL232325 DHAQ Hydrochloride, Mitoxantrone Mitoxantrone Acetate Mitoxantrone Hydrochloride Mitozantrone Mitroxone NSC 279836 NSC 287836 NSC 299195 NSC 301739 NSC 301739D NSC-279836 NSC-287836 NSC-299195 NSC-301739 NSC-301739D NSC279836 NSC287836 NSC299195 NSC301739 NSC301739D Novantron Novantrone Onkotrone Pralifan Ralenova |
||||||
Tree number(s): |
D02.455.426.559.847.117.380.625.500 D02.806.100.500 D04.615.125.380.625.500 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D008942 | ||||||
Scope note: | An anthracenedione-derived antineoplastic agent. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Analgesics Antineoplastic Agents Topoisomerase II Inhibitors |
||||||
Registry Number: | BZ114NVM5P | ||||||
CAS Type 1 Name: | 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)- | ||||||
Previous Indexing: |
Anthraquinones (1966-1986) |
||||||
Public MeSH Note: | 87 |
||||||
History Note: | 87 |
||||||
DeCS ID: | 29455 | ||||||
Unique ID: | D008942 | ||||||
NLM Classification: | QV 269 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1987/01/01 | ||||||
Date of Entry: | 1986/06/03 | ||||||
Revision Date: | 2016/07/01 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Polycyclic Compounds [D04]Polycyclic Compounds
|
Mitoxantrone
- Preferred
NSC-279836
- Narrower
NSC-287836
- Narrower
NSC-299195
- Narrower
NSC-301739
- Narrower
NSC-301739D
- Narrower
Mitroxone
- Narrower
Pralifan
- Narrower
CL-232325
- Narrower
Mitoxantrone Acetate
- Narrower
Mitoxantrone Hydrochloride
- Narrower
Novantrone
- Narrower
Onkotrone
- Narrower
Concept UI |
M0013954 |
Scope note | An anthracenedione-derived antineoplastic agent. |
Preferred term | Mitoxantrone |
Entry term(s) |
DHAQ Mitozantrone |
Concept UI |
M0350510 |
Preferred term | NSC-279836 |
Entry term(s) |
NSC 279836 NSC279836 |
Concept UI |
M0350518 |
Preferred term | NSC-287836 |
Entry term(s) |
NSC 287836 NSC287836 |
Concept UI |
M0013956 |
Preferred term | NSC-299195 |
Entry term(s) |
NSC 299195 NSC299195 |
Concept UI |
M0350519 |
Preferred term | NSC-301739 |
Entry term(s) |
NSC 301739 NSC301739 |
Concept UI |
M0350511 |
Preferred term | NSC-301739D |
Entry term(s) |
NSC 301739D NSC301739D |
Concept UI |
M0474352 |
Preferred term | Mitroxone |
Concept UI |
M0474355 |
Preferred term | Pralifan |
Concept UI |
M0350507 |
Preferred term | CL-232325 |
Entry term(s) |
CL 232325 CL232325 |
Concept UI |
M0330041 |
Preferred term | Mitoxantrone Acetate |
Entry term(s) |
Acetate, Mitoxantrone |
Concept UI |
M0330040 |
Preferred term | Mitoxantrone Hydrochloride |
Entry term(s) |
Hydrochloride, Mitoxantrone |
Concept UI |
M0013955 |
Preferred term | Novantrone |
Entry term(s) |
Novantron Ralenova |
Concept UI |
M0474353 |
Preferred term | Onkotrone |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey